Back to search results

Study of Rise&Walk InHome Device for Stroke Survivors

This study is looking at a new device called Rise&Walk InHome (RWH) for stroke survivors who have difficulty walking. The RWH is a robotic device that helps you practice stepping safely at home. We want to see if it's safe, easy to use, and helps improve walking. You might be able to join if you are 18 or older, had a stroke 3 months to 5 years ago, and have trouble walking but can stand for at least 30 minutes. The main way we'll measure success is by how far you can walk in 6 minutes over 12 weeks. The current recruitment status is unclear, and we plan to enroll 20 participants.

Study design
This is a pilot study where 20 participants will be randomly assigned to either use the Rise&Walk InHome device at home plus usual care, or receive usual care alone.
What's involved
If you are in the intervention group, you will have a Rise&Walk InHome device placed in your home and be asked to do 30-minute walking sessions four times a week for 12 weeks.
Compensation
Not stated in the trial record.
Follow-up
Your walking ability will be measured at the start, and then at 4, 8, and 12 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07250425

Development and Efficacy of a Novel, Cost-Effective Gait Training Device Utilized at Home for Stroke Survivors

Not Yet Recruiting
NAAges 18–75InterventionalTreatment
Healing Innovations
~20 participants
Updated 2026-03-09 on ClinicalTrials.gov
What's tested:Rise&Walk InHome by Healing Innovations

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
6-minute walk test
Measured over 0,4,8,12 weeks

Conditions

Stroke
Neurological Diseases or Conditions
Hemiparesis;Poststroke/CVA
Gait Disorders, Neurologic
Post Stroke Fatigue
Motor Recovery
Walking Difficulty
Balance Impairment
Falls Prevention
Hemiparesis
Mobility Limitation

Explore related trials

Stroke

NCT07250425

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Kessler Foundation

    West Orange, New Jerseystudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Julie Hartman, DPT · PRINCIPAL_INVESTIGATOR · Healing Innovations
  • Karen Nolan, PhD · PRINCIPAL_INVESTIGATOR · Kessler Foundation
  • Ben Taylor · PRINCIPAL_INVESTIGATOR · Healing Innovations

Who to contact

Karen Nolan, PhD
[email protected]
973-324-3544
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥ 18 years.
First-ever ischemic or hemorrhagic stroke confirmed by medical record.
3 months to 5 years post-stroke at time of enrollment.
Presence of lower-extremity motor impairment limiting walking function.
Able to stand for at least 30 minutes with no more than minimal assistance (with or without a device).
Medically stable and cleared by a physician to participate in moderate-intensity ambulation exercise.
Living in a home environment that can safely accommodate device installation (e.g., adequate space, appropriate flooring, and power access) as determined by the study team.
Able to understand study procedures and provide informed consent (or have a legally authorized representative), with sufficient cognitive and communication skills to follow simple instructions.
If assistance is required for transfers or device set-up, availability of a caregiver or assistant willing to participate in training and device use.

Exclusion

Unstable cardiovascular, respiratory, or other medical conditions that contraindicate moderate- to high-intensity walking exercise (e.g., unstable angina, decompensated heart failure, uncontrolled arrhythmias).
Severe musculoskeletal or orthopedic conditions limiting safe participation in supported stepping (e.g., unstable fractures, severe contractures preventing positioning in the device).
Severe spasticity or movement disorders that would preclude safe use of the device, based on investigator judgment.
Severe cognitive impairment, aphasia, or behavioral disturbance that would prevent informed consent or safe participation.
Progressive neurological conditions (e.g., progressive neurodegenerative disease) expected to significantly worsen over the 12-week study period.
Current participation in another interventional trial targeting gait or lower-extremity function.
Any other condition that, in the opinion of the investigators, would make participation unsafe or interfere with study adherence or outcome interpretation.

What this trial measures

  • 6-minute walk test0,4,8,12 weeks

    A standardized submaximal exercise test that measures functional exercise capacity by recording the total distance a participant can walk on a flat, straight course in six minutes. The primary outcome is walking distance, typically recorded in meters. Higher distances indicate better functional mobility and aerobic capacity, whereas shorter distances reflect greater impairment or reduced endurance.